A clinic-based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients

Movement Disorders

Volumn 24, Issue 7, 2009, Pages 1023-1027

  Shojaee, Seyedmehdi ^a   Sina, Farzad ^b   Farboodi, Niloofar ^a   Fazlali, Zeinab ^a   Ghazavi, Farzaneh ^a   Ghorashi, Seyed Ali ^c   Parsa, Khosro ^d   Sadeghi, Homa ^d   Shahidi, Gholam Ali ^b   Ronaghi, Mostafa ^e   Elahi, Elahe ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IVS311 3A > G; LRRK2; Parkinson's disease; R1441C; Sex ratio

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARGININE; CHILD; CYSTEINE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC SCREENING; HUMANS; IRAN; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 67651166905     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22503     Document Type: Article

References (20)

1. Rijk MD, Breteler M, Graveland G, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology 1995;45:2143-2146.
2. Wood-Kaczmar A, Gandhi S, Wood N. Understanding the molecular causes of Parkinson's disease. Trends Mol Med 2006;12: 521-528.
3. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
4. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
5. Haugarvoll K, Rademakers R, Kachergus JM, et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008;70:1456-1460.
6. Hedrich K, Winkler S, Hagenah J, et al. Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease. Mov Disord 2006;21: 1506-10510.
7. Saunders-Pullman R, Lipton RB, Senthil G, et al. Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Neurosci Lett 2006;402:92-96.
8. Illarioshkin SN, Shadrina MI, Slominsky PA, et al. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Eur J Neurol 2007;14:413-417.
9. Paisan-Ruiz C, Nath P, Washecka N, Gibbs JR, Singleton AB. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum Mutat 2008;29:485-490.
10. Berg D, Schweitzer KJ, Leitner P, et al. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 2005;128:3000-3011.
11. Zabetian CP, Samii A, Mosley AD, et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005;65:741-744.
12. Nuytemans K, Rademakers R, Theuns J, et al. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. Eur J Hum Genet 2008;16:471-479.
13. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-1169.
14. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
15. Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78: 819-824.
16. Elbaz NA. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease. Lancet Neurol 2008;7:562-564.
17. Kessler I. Epidemiologic studies of Parkinson's disease. II. A hospital based survey. Am J Epidemiol 1972;95:308-318.
18. Kessler I. Epidemiologic studies of Parkinson's disease. II. A community based survey. Am J Epidemiol 1972;96:242-254.
19. Fonzo AD, Tassorelli C, Mari MD, et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006;14:322-331.
20. Twelves D, Perkins K, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18:19-31.